2002 Healthcare: Drugs Regulation
10 Aug 2005
Pharma firms are unhappy with potential new disclosure rules, writes Adam Hill
Search results for OTC Drugs
Search filters:
By Publication
- prweek.com
Click 
to remove filters
Add Search Filters:
By Channel
- Agency (5)
- New Business (6)
- PR (10)
- Public Relations (97)
By Industry Sector
- Agencies (5)
- Financial Services (5)
- FMCG (2)
- Government / Non-Profit (16)
- Media / Entertainment (9)
- More...
- Technology (3)
- Less...
By Media
- Video (1)
The pharmacist will see you now
16 Jun 2009 | by Gemma O'Reilly
The growing number of drugs available over the counter are creating communications challenges...-the-counter (OTC) diet drug. Orlistat, manufactured under the brand name Alli by GlaxoSmithKline (GSK), has been available on prescription in the UK since 1999. But overweight people are now able to get the drug direct ... of applications to move a drug to OTC sale has increased. OTC drugs may offer a more reliable revenue stream ...
Roche's MabThera cancer drug account up for grabs
04 Oct 2010 | by Mark Banham
Pharmaceuticals giant Roche is set to launch a review for its oncology cancer care drug MabThera...., The MabThera drug is harvested from Chinese hamster ovary (CHO) cells in suspension and is supplied as sterile ... companies jostling for market share including Novartis with its lymphoma drug Lucatumumab and several new ... healthcare shop Synergy to handle comms activity for its oncology drug Xeloda. Synergy was awarded ...
On the agenda - Blood pressure drugs for over-55s
26 May 2009 | by Gemma O'Reilly
In a nutshell Everyone aged 55 and over should be taking drugs to lower their blood pressure, even...Why is this a story? The research found that drugs such as beta blockers and ACE inhibitors ... polypill' - a drug that would include a statin to lower cholesterol as well as treatment for blood pressure ... trials involving blood pressure drugs. Media coverage The story was picked up by the BBC website ...
On the agenda - Swine flu drugs cause web flurry
07 Jul 2009 | by Gemma O'Reilly
In a nutshell The public has been warned against buying anti-swine flu drug Tamiflu over...Why has he spoken out? Sir Donaldson wanted to reassure the public that the Government has stockpiled enough vaccines of the real Tamiflu drug. His interview aired as news broke that the UK could soon ... drugs online. It launched a Pharmacy logo' last year for accredited online pharmacies to reassure ...
On the agenda - New drug could add years to life
14 Jul 2009 | by Gemma O'Reilly
In a nutshell A drug used to stop transplant recipients rejecting their new organs can...in mammals. But the drug is too dangerous to use as an anti-ageing pill for humans in its current form ... Island drug "adds decade to life"'. The story was also discussed on GMTV by the show's health and medical ... on mice and it did not mean the drug would work on humans. STATS 38% increase in life expectancy ...
On the agenda: Use of leukaemia drug to treat MS
05 May 2009 | by Gemma O'Reilly
In a nutshell A drug licensed for the treatment of leukaemia has been found to dramatically reduce...What's the big deal? Professor Gavin Giovanni, of Barts and The London School of Medicine and Dentistry, part of Queen Mary, University of London, has said the drug could revolutionise the treatment of MS. He was speaking to the American Academy of Neurology in Seattle last week. Manufacturer Merck ...
Healthcare: On the Agenda - Cheap drugs for dementia patients
16 Mar 2012
A King's College London study has found drugs that cost only 50p a day could help 450,000 advanced sufferers of dementia in the UK. The two drugs, Donepezil, more commonly known as Aricept, and Memantine ... certain point because the drugs are thought to stop adding any benefit. However, it is now claimed ...
Moving together: Is there a global convergence in drug evaluation?
14 Oct 2010 | by Suzanne Elvidge
Technology Assessments The increase in limitations in access to drugs in both the public and private sector ... Agency for Drugs and Technologies in Health (CADTH) While there is an overall degree of convergence ... : Is there a global convergence in drug evaluation? ...
Chamberlain PR wins Novartis diabetes drug brief following competitive pitch
18 Oct 2010 | by Mark Banham
Novartis has handed a comms account for diabetes drug Galvus to Chamberlain PR following a four...immediately. Galvus is an oral anti-diabetic drug that helps to reduce hyperglycemia (high blood sugar ... it merged with C W. Since the beginning of the year, Chamberlain has picked up accounts including drugs ...
Additional Information
Campaign Jobs
- Senior Planner/ Buyer - high-end luxury client! Ultimate Asset £25000.00 - £30000.00 per annum + GREAT bonus + bens, London
- SEO Strategist Ultimate Asset £35000.00 - £40000.00 per annum + Grea benefits, London
- Insight Executive/Manager Elizabeth Norman International £40000 per annum, West London
- Marketing Executive - leading performance consultancy - up to £35K depending on experience f1 Recruitment Up to 35K depending on experience, West London
- SAS Senior Analyst- Direct Marketing Agency Harnham Search and Selection £45000 - £55000 per annum + Package, London
Most viewed
- Phones4U horror spot tops 2011's most complained about ads
- Sorrell says Adam & Eve acquisition 'shows DDB needed some help'
- National Trust launches Wallace and Gromit ads
- M&M characters test out 'British' costumes in Jubilee ad
- 'Bigger. Fatter. Gypsier.' campaign will be investigated by watchdog
- Joint finally opens for business
Most commented
Making the most of mobile
Welcome to the first incarnation of a new element in Campaign in which we invite experts to burrow beneath the surface of the catch-all that is "digital". Google, Isobar Mobile, JWT London, LBI and MBA share their insights on mobile.
